ADAMTS like 4
Zuletzt aktualisiert 1 Apr 2026
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The ADAMTSL4 gene provides instructions for making a protein that is found throughout the body. The ADAMTSL4 protein is released from cells into the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells. The ADAMTSL4 protein binds to other proteins within the extracellular matrix. One of these proteins is called fibrillin-1. Fibrillin-1 proteins bind to each other and to other proteins to form threadlike filaments called microfibrils. Research suggests that ADAMTSL4 binds to fibrillin-1 to promote microfibril assembly in many tissues. Within the eyes, microfibrils form small bundles called zonular fibers that hold the lenses of the eyes in their central position. The lens is a clear structure at the front of the eye that helps focus light.
Normal function
The ADAMTSL4 gene provides instructions for making a protein that is found throughout the body. The ADAMTSL4 protein is released from cells into the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells. The ADAMTSL4 protein binds to other proteins within the extracellular matrix. One of these proteins is called fibrillin-1. Fibrillin-1 proteins bind to each other and to other proteins to form threadlike filaments called microfibrils. Research suggests that ADAMTSL4 binds to fibrillin-1 to promote microfibril assembly in many tissues. Within the eyes, microfibrils form small bundles called zonular fibers that hold the lenses of the eyes in their central position. The lens is a clear structure at the front of the eye that helps focus light.
Conditions referring to this gene or chromosome
Other names
DKFZP434K1772
Related patient information and medicines
Patient information leaflet
Kann ich Atorvastatin und Ballaststoffpräparate zusammen einnehmen?
Taking fibre supplements at the same time as atorvastatin can lower the amount of medicine your body absorbs. Using ot... Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.
Patient information leaflet
Kann ich Ciprofloxacin und Milchprodukte zusammen einnehmen?
Taking ciprofloxacin at the same time as dairy products (like milk, cheese, or yoghurt) can significantly reduce the amount of medicine that gets into your bloodstream. ...ts are safe to take togetherDisclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice..
Patient information leaflet
Kann ich Levothyroxin und Vitamin D zusammen einnehmen?
It is best absorbed by your body when taken with a meal that contains some fat (such as eggs, avocado, nuts, or dairy). Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice. ...armacist, or another qualified healthcare professional before making.
Patient information leaflet
Kann ich Anastrozol und Levothyroxin zusammen einnehmen?
Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Disclaimer This information is for general educational purposes only and should not be reli... Always consult your GP, pharmacist, or another qualified healthcare professional before making decisions.
Patient information leaflet
Kann ich Lercanidipin und Levothyroxin zusammen einnehmen?
However, if your thyroid levels are not well-controlled, it can affect how your blood pressure medication works. Why this happens Lercanidipine is a calcium channel blocker used for high blood pressure, and levothyroxine is a hormone replacement for an underactive thyroid. They do not interfere with each other's absorption or metabolism. However,.
Patient information leaflet
Neugeborenengelbsucht
Neonatal jaundice is very common in the first two weeks of a baby's life. It is usually harmless but may be due to a serious cause which needs treatment in hospital. Neonatal jaundice is more likely to have a serious cause if it is seen in the first 24 hours of life or doesn't disappear by 2 weeks of age. All babies with jaundice should be seen by.
Weiterführende Lektüre und Referenzen
- ADAMTS like 4; MedlinePlus, National Library of Medicine.
- Chandra A, Aragon-Martin JA, Hughes K, Gati S, Reddy MA, Deshpande C, Cormack G, Child AH, Charteris DG, Arno G. A genotype-phenotype comparison of ADAMTSL4 and FBN1 in isolated ectopia lentis. Invest Ophthalmol Vis Sci. 2012 Jul 24;53(8):4889-96. doi: 10.1167/iovs.12-9874.
- Christensen AE, Fiskerstrand T, Knappskog PM, Boman H, Rodahl E. A novel ADAMTSL4 mutation in autosomal recessive ectopia lentis et pupillae. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6369-73. doi: 10.1167/iovs.10-5597. Epub 2010 Aug 11.
- Gabriel LA, Wang LW, Bader H, Ho JC, Majors AK, Hollyfield JG, Traboulsi EI, Apte SS. ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds fibrillin-1 microfibrils and accelerates microfibril biogenesis. Invest Ophthalmol Vis Sci. 2012 Jan 31;53(1):461-9. doi: 10.1167/iovs.10-5955.
- Hubmacher D, Apte SS. Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. Cell Mol Life Sci. 2011 Oct;68(19):3137-48. doi: 10.1007/s00018-011-0780-9. Epub 2011 Aug 20.
- Rodahl E, Mellgren AEC, Boonstra NE, Knappskog PM. ADAMTSL4-Related Eye Disorders. 2012 Feb 16 [updated 2020 Jul 9]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK84111/
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
1 Apr 2026 | Neueste Version
1 Apr 2026 | Ursprünglich veröffentlicht
Nehmen Sie an der Diskussion teil
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Fragen, teilen, verbinden.
Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.